0001209191-23-013183.txt : 20230227 0001209191-23-013183.hdr.sgml : 20230227 20230227161817 ACCESSION NUMBER: 0001209191-23-013183 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230223 FILED AS OF DATE: 20230227 DATE AS OF CHANGE: 20230227 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Spada Alfred P. CENTRAL INDEX KEY: 0001580465 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36003 FILM NUMBER: 23675127 MAIL ADDRESS: STREET 1: C/O CONATUS PHARMACEUTICALS INC. STREET 2: 4365 EXECUTIVE DRIVE, SUITE 200 CITY: SAN DIEGO STATE: CA ZIP: 92121 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Histogen Inc. CENTRAL INDEX KEY: 0001383701 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 203183915 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 10655 SORRENTO VALLEY ROAD STREET 2: SUITE 200 CITY: San Diego STATE: CA ZIP: 92121 BUSINESS PHONE: (858) 526-3100 MAIL ADDRESS: STREET 1: 10655 SORRENTO VALLEY ROAD STREET 2: SUITE 200 CITY: San Diego STATE: CA ZIP: 92121 FORMER COMPANY: FORMER CONFORMED NAME: Conatus Pharmaceuticals Inc. DATE OF NAME CHANGE: 20140729 FORMER COMPANY: FORMER CONFORMED NAME: Conatus Pharmaceuticals Inc DATE OF NAME CHANGE: 20061214 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2023-02-23 0 0001383701 Histogen Inc. HSTO 0001580465 Spada Alfred P. C/O HISTOGEN INC. 10655 SORRENTO VALLEY ROAD, SUITE 200 SAN DIEGO CA 92121 0 1 0 0 See Remarks Stock Option (right to buy) 1.041 2023-02-23 4 A 0 106793 0.00 A 2033-02-23 Common Stock 106793 106793 D This option was issued to the Reporting Person as an inducement to employment with the Issuer. It is intended to be an inducement grant in accordance with Rule 5635(c)(4) of the Nasdaq Listing Rules. 1/4 of the shares subject to the option vest one year after the date of grant, on 2/1/2024, and the remaining 1/36 of the shares vest on a monthly basis thereafter. Executive Vice President and Chief Scientific Officer /s/ Susan A. Knudson as attorney-in-fact for Alfred P. Spada, Ph.D. 2023-02-27